Artemisinin and Procyanidins loaded multifunctional nanocomplexes alleviate atherosclerosis via simultaneously modulating lipid influx and cholesterol efflux.

Abstract

The development of new reagents combining with nanotechnology has become an efficient strategy for improving the immune escaping ability and increasing local drug concentration for natural compounds with low therapy efficiency. In this study, we prepared biomimetic membrane-coated Prussian blue nanoparticles (PB NPs) for the treatment of atherosclerosis, using the function of Artemisinin (ART) and Procyanidins (PC) on the lipid influx and cholesterol efflux of macrophages, two logical steps involved in the plaque progression. In vitro results indicated that the prepared nanocomplexes have significant scavenging effect on ROS and NO, followed by inhibiting NF-κB/NLRP3 pathway, leading to the suppression of lipid influx. Meanwhile, they can notably reduce the uptake and internalization of oxLDL through significantly enhancing AMPK/mTOR/autophagy pathway, accompanied by promoting cholesterol efflux. In vivo study showed that the improved biocompatibility and immune-escape ability of nanocomplexes allowed less drug clearance during the circulation and high drug accumulation in the atherosclerotic plaque of ApoE-/- mice model. More importantly, the ART and PC co-loaded nanocomplexes showed the high efficacy against atherosclerosis of ApoE-/- mice model with both 8-week low dosage treatment or 1-week high dosage treatment. These findings indicated that ART and PC co-loaded nanocomplexes was promising for the targeted treatment of atherosclerosis.

• Authors: Hongyan Zhou, Peidong You, Hao Liu, Jialong Fan, Chunyi Tong, Anning Yang, Yideng Jiang, Bin Liu
• Journal: Journal of controlled release : official journal of the Controlled Release Society (J Control Release) Vol. 341 Pg. 828-843 (01 2022) ISSN: 1873-4995 [Electronic] Netherlands
• PMID: 34942304 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2021. Published by Elsevier B.V.

Chemical References

• Artemisinins
• Proanthocyanidins
• Cholesterol

Topics

• Animals
• Artemisinins (therapeutic use)
• Atherosclerosis (drug therapy, metabolism)
• Cholesterol (metabolism)
• Mice
• Plaque, Atherosclerotic (drug therapy)
• Proanthocyanidins (therapeutic use)